Effects of a new 12-lipoxygenase inhibitor, daphnodorin A, on angiotensin II-induced vascular contraction in hamster

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 60, Issue 2, 1999, Pages 135-138

  Takai, S ^a   Jin, D ^a   Sakaguchi, M ^a   Kirimura, K ^a   Ikeda, J ^a   Baba, K ^a   Fujita, T ^a   Miyazaki, M ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DAPHNODORIN A; DAPHNODORIN B; HORMONE INHIBITOR; LIPOXYGENASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; HAMSTER; MALE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION;

ANIMALIA; CRICETINAE;

EID: 0032904364     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.1998.0020     Document Type: Article

References (19)

1. Miyazaki M., Okamura T., Okunishi H., Toda N. Vascular angiotensin converting enzyme in the development of renal hypertension. J Cardiovasc Pharmacol 1986; 8(suppl. 10): S58-S61.
2. Okamura T., Miyazaki M., Inagami T., Toda N. Vascular reninangiotensin system in two-kidney, one clip hypertensive rats. Hypertension 1986; 8: 560-565.
3. Shiota N., Miyazaki M., Okunishi H. Increase of angiotensin converting enzyme gene expression in the hypertensive aorta. Hypertension 1992; 20: 168-174.
4. Ryan M. J., Boucher D. M., Cohen D. M., et al. Antihypertensive effects of CI-907 (indolapril): A novel nonsulfhydryl angiotensin converting enzyme inhibitor. J Pharmacol Exp Ther 1984; 228: 312-318.
5. Nozawa K., Tuck M. L., Golub M. S., Eggena P., Nadel J. L., Stern N. Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats. Am J Physiol 1990; 259: H1774-H1780.
6. Stern N., Kisch E. S., Knoll E. Platelet lipoxygenase in spontaneously hypertensive rats. Hypertension 1996; 27: 1149-1152.
7. Stern N., Nozawa K., Golub M., Eggena E., Knoll E., Tuck M. L. The lipoxygenase inhibitor phenidone is a potent hypotensive agent in the spontaneously hypertensive rat. Am J Hypertens 1993; 6: 52-58.
8. Takai S., Jin D., Hara K., Takami H., Fujita T., Miyazaki M. 12-Hydroxyeicosatetraenoic acid directly potentiates angiotensin II-induced vascular contraction. Eur J Pharmacol (in press).
9. Baba K., Takeuchi K., Hamasaki F., Kozawa M. Chemical studies on constituents of the Thymelaeaceous plants. I. Structures of two new flavans from Daphne odora THUNB. Chem Pharm Bull 1986; 34: 595-602.
10. Baba K., Takeuchi K., Doi M., Kozawa M. Chemical studies on the constituents of the Thymelaeaceous plants. II. Stereochemistry of daphnodorin A and daphnodorin B. Chem Pharm Bull 1986; 34: 1540-1545.
11. Sakuma S., Fujimoto Y., Tsunomori S., Tagano H., Nishida H., Baba K., Fujita T. Effects of daphnodorin A, B and C, new flavans isolated from traditional chinese medicine, on the 12-lipoxygenase and cyclooxygenase metabolism of arachidonic acid in rabbit platelets. Prostagrandins Leukot Essent Fatty Acids 1998; 58: 143-146.
12. 2+ signal generation. J Clin Invest 1987; 80: 248-257.
13. 2+-force relationship studied with fura-2 during stimulation of rat aortic smooth muscle. Am J Physiol 1988; 254: H840-H854.
14. Sekiya F., Takagi J., Usui T., Kawajiri K., Kobayashi Y., Sato F., Saito Y. 12S-hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation. Biochem Biophys Res Commun 1991; 179: 345-351.
15. Naftilan A. J., Gilliland G., Eldridge C. S., Kraft A. S. Induction of the proto-oncogene c-jun by angiotensin II. Mol Cell Biol 1990; 10: 5536-5540.
16. Schelling H., Fischer H., Ganten D. Angiotensin and cell growth: A link to cardiovascular hypertrophy? J Hypertens 1991; 9: 3-15.
17. Miyazaki M., Sakonjo S., Takai S., Shiota N. Anti-atherosclerotic action of ACE inhibitors. J Hypertens 1996; 14: (suppl. 1), S138.
18. Takai S., Shiota N., Kobayashi S., Matsumura E., Miyazaki M. Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta. FEBS Lett 1997; 412: 86-90.
19. Natarajan R., Gonzales N., Lanting L., Nadler J. L. Role of the lipoxygenase pathway in angiotensin ii-induced vascular smooth muscle cell hypertrophy. Hypertension 1994; 23: I-142-I-147.